Clinical management of established pre-eclampsia

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 13, Issue 1, 1999, Pages 77-93

  Moran, Paul ^a   Davison, John M ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Anticonvulsants; Antihypertensive agents; Diagnosis; Pre eclampsia; Pregnancy; Therapeutic use; Therapy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAMETHASONE; BIOCHEMICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE;

BLOOD CLOTTING PARAMETERS; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CLINICAL EXAMINATION; DELIVERY; DEPRESSION; DRUG CHOICE; ESSENTIAL HYPERTENSION; FEMALE; FETUS DISEASE; FETUS MONITORING; FLUID THERAPY; HEADACHE; HOSPITALIZATION; HUMAN; HYPOTENSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAUTERINE GROWTH RETARDATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LIVER FUNCTION TEST; MATERNAL CARE; MATERNAL HYPERTENSION; MEDICAL RECORD; NAUSEA; ORAL DRUG ADMINISTRATION; OUTPATIENT; PLACENTA DISORDER; PRACTICE GUIDELINE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SUBLINGUAL DRUG ADMINISTRATION; TACHYCARDIA; THROMBOCYTE COUNT; VERTIGO; XEROSTOMIA;

ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; FEMALE; FETAL MONITORING; GUIDELINES; HUMANS; HYPERTENSION; PRE-ECLAMPSIA; PREGNANCY;

EID: 0009664128     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.1999.0007     Document Type: Article

References (42)

1. Anonymous (1992) Bed rest and non-proteinuric hypertension in pregnancy. Lancet 339: 1023-1024 (editorial).
2. *Anthony J, Johanson R & Dommisse J (1994) Critical care management of severe pre-eclampsia. Fetal and Maternal Medicine Review 6: 219-229.
3. *Australasian Society for the Study of Hypertension in Pregnancy (1993) Consensus report: management of hypertension in pregnancy. 8th World Congress of Hypertension in Pregnancy, Buenos Aires,Argentina, 8-12 November 1992.
4. Brown MA & Whitworth JA (1991) Recording diastolic blood pressure in pregnancy. British Medical Journal 303: 120-121.
5. Cockburn J, Moar VA, Ounsted M & Redman CWG (1982) Final report of study on hypertension during pregnancy: the effects of specific treatment on the growth and development of the children. Lancet I: 647-649.
6. Cotton DB, Lee W, Huhta JC & Dorman KR (1988) Hemodynamic profile of severe pregnancy induced hypertension. American Journal of Obstetrics and Gynecology 158: 523-529.
7. Crowley P (1989) Promoting pulmonary maturity. In Chalmers I, Enkin M & Keirse MJNC (eds) Effective Care in Pregnancy and Childbirth. Oxford: Oxford University Press.
8. Davison JM (1997) Edema in pregnancy. Kidney International 51 (supplement 59): S90-S96.
9. DHSS (1991) Hypertensive disorders of pregnancy. In Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1985-87, pp 17-27. London: HMSO.
10. Douglas KA & Redman CWG (1994) Eclampsia in the United Kingdom. British Medical Journal 309: 1395-1400.
11. Duley L, Carroli G, Belizan J et al (1995) Which anticonvulsant for women with eclampsia - evidence from the collaborative eclampsia trial. Lancet 345: 1455-1463.
12. Erley CM & RislerT (1994) Microalbuminuria in primary hypertension: is it a marker of glomerular damage? Nephrology, Dialysis,Transplantation 9: 1713-1715.
13. Friedman EA & Neff RK (1977) Pregnancy outcome as related to hypertension, edema and proteinuria. In Lindheimer MD, Katz AI & Zuspan FP (eds) Hypertension in Pregnancy. New York: Wiley.
14. *Gallery EDM (1993) The role of volume expansion in clinical management of hypertensive pregnant women. Hypertension in Pregnancy 12(2): ix-xiii.
15. Gallery EDM, Hunyor SN & Gyory AZ (1979) Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Quarterly Journal of Medicine 48: 593-602.
16. *Hutton JD, James DK, Stirrat GM et al (1992) Management of severe pre-eclampsia and eclampsia by UK consultants. British Journal of Obstetrics and Gynaecology 99: 554-556.
17. Lee W & Cotton DB (1997) Hemodynamic characterization of severe pregnancy induced hypertension. In Walker JJ and Gant NF (eds) Hypertension in Pregnancy, pp 77-99. London: Chapman & Hall.
18. Manning FA (1997) Fetal biophysical profile: a critical appraisal. Fetal and Maternal Medicine Review 9: 103-123.
19. Manning FA, Morrison I, Harman CR et al (1987) Fetal assessment based on the fetal biophysical profile score: experience in 19 221 referred high risk pregnancies. II. The false negative rate by frequency and aetiology. American Journal of Obstetrics and Gynecology 157: 880-884.
20. Mantel GD & Makin JD (1997) Low dose dopamine in postpartum pre-eclamptic women with oliguria: a double-blind placebo controlled, randomised trial. British Journal of Obstetrics and Gynaecology 104: 1180-1183.
21. Olah KS, Redman CWG & Gee H (1993) Management of severe, early pre-eclampsia: is conservative management justified? European Journal of Obstetric and Gynaecological Reproductive Biology 51: 175-180.
22. *Pritchard JA, Cunningham FG & Pritchard SA (1984) The Parkland Hospital protocol for treatment of eclampsia: evaluation of 245 cases. American Journal of Obstetrics and Gynecology 148: 951-963.
23. Rayburn WF, Schnoor TA, Brown DL & Smith CV (1993) 'White coat' hypertension during pregnancy. Hypertension in Pregnancy 12: 191-197.
24. Redman CWG (1995) Hypertension in pregnancy. In De Swiet M (ed.) Medical Disorders in Obstetric Practice 3rd edn, pp 182-225. Oxford: Blackwell Scientific.
25. *Redman CWG & Roberts JM (1993) Management of pre-eclampsia. Lancet 3: 1451-1454.
26. Redman CWG, Beilin LJ, Bonnar J et al (1976) Plasma urate measurements in predicting fetal death in hypertensive pregnancies. Lancet 1: 1370-1373.
27. Rossa FW, Bosco LA, Graham CF et al (1989) Neonatal anuria with maternal angiotensin-converting enzyme inhibition. Obstetrics and Gynecology 74: 371-374.
28. Royal College of Obstetricians and Gynaecologists (1996) Ante-natal corticosteroids to prevent respiratory distress syndrome. RCOG Guideline 1996, No. 7.
29. Rubin PC, Butters L, Clark DM et al (1983) Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1: 431-434.
30. Saudan PJ, Brown MA, Farrell T & Shaw L (1997) Improved methods of assessing proteinuria in hypertensive pregnancy. British Journal of Obstetrics and Gynecology 104: 1159-1164.
31. *Schiff E, Friedman SA, Kao L & Sibai BM (1996) The importance of urinary protein excretion during conservative management of severe pre-eclampsia. American Journal of Obstetrics and Gynecology 175: 1313-1316.
32. *Sibai BM & Anderson GD (1986) Pregnancy outcome of intensive therapy in severe hypertension in first trimester. Obstetrics and Gynecology 67: 517-522.
33. Sibai BM, Mercer BM, Schiff E & Friedman SA (1994) Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks gestation: randomised controlled trial. American Journal of Obstetrics and Gynecology 171: 818-822.
34. *Sturgiss SN, Lindheimer MD & Davison JM (1992) Treatment of hypertension during pregnancy: drugs to be avoided and drugs to be used. In Andreucci VE & Fine LG (eds) International Yearbook of Nephrology, pp 163-196. Berlin: Springer.
35. Tuffnell DJ, Lilford RJ, Buchan PC et al (1992) Randomised controlled trial of day care for hypertension in pregnancy. Lancet 339: 224-227.
36. Twaddle S & Harper V (1992) Day care and pregnancy hypertension. Lancet 339: 813-814.
37. Vink GJ, Moodley J & Philpott RH (1980) Effect of dihydralazine on the fetus in the treatment of maternal hypertension. Obstetrics and Gynecology 55: 519-522.
38. Visser W & Wallenburg HCS (1995) A comparison between the haemodynamic effects of oral nifedipine and intravenous dihydralazine in patients with severe pre-eclampsia. Journal of Hypertension 13: 791-795.
39. Waisman GD, Mayorga LM, Camera MI et al (1988) Magnesium plus nifedipine potentiation of the hypotensive effect in pre-eclampsia? American Journal of Obstetrics and Gynecology 159: 308-309.
40. Wallenburg HCS (1988) Hemodynamics in hypertensive pregnancy. In Rubin PC (ed.) Hypertension in Pregnancy, pp 66-101. New York: Elsevier.
41. White P (1949) Pregnancy complicating diabetes. American Journal of Medicine 7: 609-616.
42. Xenakis EMJ, Piper JM, Field N et al (1997) Pre-eclampsia: is induction of labour more successful? Obstetrics and Gynecology 89: 600-603.